-
Novel Meta-Analysis Shows VATS Improves Overall Survival in Early-Stage Lung Cancer
Dr. Jacie Jiaqi Law shared results from a first-ever meta-analysis demonstrating that VATS reduces mortality risk without compromising disease-free survival.
More News from #WCLC25
-
Ivonescimab-Chemotherapy Combo Shows Promise as Post-TKI Option in EGFR-Mutant NSCLC
Dr. Jonathan W. Goldman reported that ivonescimab plus chemotherapy yielded a consistent PFS benefit across subgroups.
-
ARROS-1 Findings Reinforce Potential of Zidesamtinib in Pretreated ROS1-Altered NSCLC
The highly ROS1-selective TKI showed durable responses in previously treated patients with ROS1-altered NSCLC, according to data presented by Dr. Alexander E. Drilon.